Ffg Partners, LLC Novo Nordisk A S Transaction History

Ffg Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 09, 2024	SELL	$119.07 - $145.42 $9.89 Million - $12.1 Million	-83,076 Closed	0 $0
Q2 2024 Dec 09, 2024	SELL	$122.71 - $146.91 $2.51 Million - $3.01 Million	-20,458 Reduced 19.76%	83,076 $11.9 Billion
Q1 2024 Dec 09, 2024	BUY	$102.11 - $135.92 $28,182 - $37,513	276 Added 0.27%	103,534 $13.3 Billion
Q4 2023 Dec 03, 2024	BUY	$87.78 - $105.45 $9.06 Million - $10.9 Million	103,258 New	103,258 $10.7 Billion

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $252B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Ffg Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ffg Partners, LLC with notifications on news.